Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia

Viruses. 2022 Dec 30;15(1):109. doi: 10.3390/v15010109.

Abstract

Cervical cancer is the eighth most frequent cancer in Saudi Arabia, and most cases are associated with human papillomavirus (HPV) types 16 and 18. HPV-induced carcinogenesis may be associated with the intra-type variant, genetic mutation, or the continuous expression of viral oncogenes E6 and E7. Infection efficiency and virus antigenicity may be affected by changes in the L1 gene. Thus, this retrospective cohort study analyzed E6, E7, and L1 gene mutations in cervical specimens collected from Saudi women positive for HPV16 or HPV18 infection. HPV16 and HPV18 lineages in these specimens were predominantly from Europe. The L83V mutation in the E6 gene of HPV16 showed sufficient oncogenic potential for progression to cervical cancer. By contrast, the L28F mutation in the E7 gene of HPV16 was associated with a low risk of cervical cancer. Other specific HPV16 and HPV18 mutations were associated with an increased risk of cancer, cancer progression, viral load, and age. Four novel mutations, K53T, K53N, R365P, and K443N, were identified in the L1 gene of HPV16. These findings for HPV16 and HPV18 lineages and mutations in the E6, E7, and L1 genes among women in Saudi Arabia may inform the design and development of effective molecular diagnostic tests and vaccination strategies for the Saudi population.

Keywords: E6 gene; E7 gene; HPV16; HPV18; L1 gene; cancer progression; cervical cancer; lineages; mutations; variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Human Papillomavirus Viruses
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 18 / genetics
  • Humans
  • Oncogene Proteins, Viral* / genetics
  • Papillomavirus E7 Proteins / genetics
  • Papillomavirus Infections*
  • Repressor Proteins / genetics
  • Retrospective Studies
  • Saudi Arabia / epidemiology
  • Uterine Cervical Neoplasms* / epidemiology

Substances

  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Repressor Proteins

Grants and funding

This work was supported by King Faisal Specialist Hospital and Research Centre, funding number: RAC 1005-033.